在全身性硬化症中推进胃肠道微生物群研究:从先前的研究中吸取的经验教训和加速发现机会
Chiara Bellocchi1, Elizabeth R Volkmann2
1Department of Clinical Sciences and Community Health, University of Milan, Dipartimento di Eccellenza 2023-2027, Milan, Italy; Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Via Pace 9, Milano 20122, Italy.
Rheumatic diseases clinics of North America
|April 17, 2025
概括
系统性硬化症 (SSc) 与肠道微生物组的变化有关. 研究突出了特定的微生物模式和肠道代谢组,探索微生物组操纵用于SSc预防.
科学领域:
- 胃肠道学和免疫学
- 微生物组研究 微生物组研究
- 系统性硬化症的发病源 系统性硬化症的发病源
背景情况:
- 肠道功能失调是系统性硬化症 (SSc) 患者的公认特征.
- 胃肠道 (GI) 微生物群的变化发生在SSc疾病进展的早期.
- 已经确定了与SSc表型相关的特定微生物特征.
研究的目的:
- 审查了解SSc.肠道微生物群的最新进展.
- 突出GI微生物组研究中的技术创新.
- 探索SSc.中的GI代谢组的新兴领域.
- 讨论GI微生物组操纵用于SSc预防的策略.
主要方法:
- 关于肠道微生物组和SSc.的最新研究的文献综述.
- 对聚焦于微生物组分析技术进步的研究进行分析.
- 检查有关消化道代谢的新兴研究.
- 综合了针对肠道肠道微生物组的治疗策略的数据.
主要成果:
- 胃肠道微生物组的显著变化与SSc.有关.
- 不同的微生物形状与不同的SSc表型有关.
- 消化道代谢组是SSc研究的新兴研究领域.
- 目前正在研究各种调节肠道微生物群的方法.
结论:
- 肠道微生物组在SSc病原发生过程中发挥作用,尽管因果关系尚未被证明.
- 了解微生物特征和代谢组为早期诊断和向治疗提供了潜力.
- 调节肠道微生物组为开发预防SSc进展的预防策略提供了一个有希望的途径.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...


